About Aviapharma
Developer and distributor of own and licensed pharmaceutical products, focusing on womens health, urology, dermatology, allergy, and general OTC. The company offers a portfolio of pharmaceutical solutions aimed at enhancing well-being across various age groups and therapeutic areas. It provides both self-developed and licensed pharmaceuticals, medical devices, cosmetics, and food supplements. The company is dedicated to improving lives through its products.
- Headquarter Danderyd, Sweden
- Founders Jacob Calmvik
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Aviapharma
Unlock access to complete
Unlock access to complete
Funding Insights of Aviapharma
Investors in Aviapharma
Aviapharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Impilo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Impilo is focused on healthcare investments in Nordic regions.
|
Locked | Locked | Locked |
Investor details for Aviapharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aviapharma
Investment portfolio details for Aviapharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aviapharma
Detailed financials for Aviapharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aviapharma Comparisons
Peer comparison for Aviapharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aviapharma
Detailed competitors of Aviapharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aviapharma
Complete news archive for Aviapharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aviapharma
Aviapharma was founded in 2016 and raised its 1st funding round 8 years after it was founded.
Aviapharma is headquartered in Danderyd, Sweden. It is registered at Danderyd, Stockholm County, Sweden.
Jacob Calmvik is the current CEO of Aviapharma. They have also founded this company.
Developer and distributor of own and licensed pharmaceutical products, focusing on womens health, urology, dermatology, allergy, and general OTC. The company offers a portfolio of pharmaceutical solutions aimed at enhancing well-being across various age groups and therapeutic areas. It provides both self-developed and licensed pharmaceuticals, medical devices, cosmetics, and food supplements. The company is dedicated to improving lives through its products.
Aviapharma has 1 investor. Key investors include Impilo.